Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
O Miltiadous, M Hou, JB Bussel - Blood, The Journal of the …, 2020 - ashpublications.org
Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
[HTML][HTML] Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
O Miltiadous, M Hou, JB Bussel - Blood, 2020 - Elsevier
Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
[HTML][HTML] Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
O Miltiadous, M Hou, JB Bussel - Blood, 2020 - ncbi.nlm.nih.gov
Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.
O Miltiadous, M Hou, JB Bussel - Blood, 2020 - europepmc.org
Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
O Miltiadous, M Hou, JB Bussel - Blood, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Immune thrombocytopenia (ITP) is the most
common acquired thrombocytopenia after chemotherapy-induced thrombocytopenia …
common acquired thrombocytopenia after chemotherapy-induced thrombocytopenia …
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment
O Miltiadous, M Hou, JB Bussel - Blood, 2020 - pubmed.ncbi.nlm.nih.gov
Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment.
O Miltiadous, M Hou, JB Bussel - Blood, 2020 - europepmc.org
Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia after
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …
chemotherapy-induced thrombocytopenia. Existing guidelines describe the management …